Veritable’s OptiNose OPTN Stock Holding History

Veritable’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$90K	–	925
2021 Q3	$90K	Hold	2,000	–	–	﹤0.01%	865
2021 Q2	$93K	Hold	2,000	–	–	﹤0.01%	853
2021 Q1	$111K	Hold	2,000	–	–	﹤0.01%	819
2020 Q4	$124K	Hold	2,000	–	–	﹤0.01%	771
2020 Q3	$117K	Hold	2,000	–	–	﹤0.01%	717
2020 Q2	$223K	Sell	2,000 -88	-4%	-$6.26K	﹤0.01%	681
2020 Q1	$141K	Buy	2,088 +39	+2%	+$3.93K	﹤0.01%	691
2019 Q4	$283K	Hold	2,049	–	–	0.01%	695
2019 Q3	$215K	Buy	2,049 +49	+2%	+$4.89K	﹤0.01%	746
2019 Q2	$212K	Hold	2,000	–	–	﹤0.01%	748
2019 Q1	$309K	Hold	2,000	–	–	0.01%	636
2018 Q4	$186K	Hold	2,000	–	–	﹤0.01%	741
2018 Q3	$373K	Hold	2,000	–	–	0.01%	578
2018 Q2	$839K	Hold	2,000	–	–	0.02%	383
2018 Q1	$601K	Buy	+2,000	New	+$554K	0.01%	447

Other funds holding OPTN

MPU

MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Veritable's OPTN Position: Q4 2021 in Review

Veritable sold out of OptiNose (OPTN) in Q4 2021, closing a stake of 2,000 shares — an estimated $90K sold.

Veritable first reported a position in OPTN in Q1 2018 and held it in 15 quarters. The position peaked at $839K in Q2 2018. 44 funds tracked by Wall St. Rank hold OPTN as of Q4 2021.

Veritable reported no remaining OptiNose position as of Q4 2021 after selling out during the quarter.
Veritable sold 2,000 OptiNose shares in Q4 2021, an estimated $90K.
Veritable first reported a position in OptiNose in Q1 2018 and held it in 15 quarters.
Veritable's OptiNose position peaked at $839K in Q2 2018.
44 funds tracked by Wall St. Rank held OptiNose as of Q4 2021.

Based on Veritable's 13F filing for Q4 2021, filed 14 Feb 2022.